01 1Cipla
01 1PANTOPRAZOLE SODIUM USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2016-07-22
Pay. Date : 2016-06-20
DMF Number : 17720
Submission : 2004-09-30
Status : Active
Type : II
20
Cipla Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PANTOPRAZOLE SODIUM USP, with a corresponding US DMF Number 17720.
Remarkably, this DMF maintains an Active status since its submission on September 30, 2004, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 22, 2016, and payment made on June 20, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
